Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Tecan CEO David Martyr forms new leadership team


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-01-30 07:17:38 -

Tecan Group AG /
Tecan CEO David Martyr forms new leadership team
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

Männedorf, Switzerland, January 30, 2013 - The Tecan Group (SIX Swiss Exchange:
TECN) today announced that with the implementation of its growth strategy there
will also be some changes in the leadership team. Dr. David Martyr, who became
the new CEO of the Company in October 2012, is using the opportunity to
reorganize and strengthen the capabilities of the leadership team.

David Martyr said: "Tecan is a very strong brand in our industry and has an
excellent basis for future accelerated growth. With the expected start of the
commercial supply of instruments to our partners from two major OEM 
programs within this year, we are preparing already for significant growth in the near future. For the mid and long-term development of our business it is essential that we have the right leadership team with extensive domain knowledge, experience and capabilities. Through this renewal process of the management team in various positions, I would like to take the opportunity to strengthen the capabilities of the leadership team in a targeted manner." In the context of this renewal process, Dr. Bernhard Grob, who has been Head of the Partnering Business division and member of the Management Board since January 2011, will be leaving the Company. The search for a successor is underway. Tecan's Board of Directors and CEO thank Bernhard Grob for his strong engagement and the important service of developing Tecan's Partnering Business and wish him all the best for the future. The position of the Head of the Life Sciences division was already vacant at the entry of David Martyr. The search for a successor is in a very advanced state and an announcement of this position is expected in the near future. With the increased importance of business and academic partnerships, licensing as well as potential mergers and acquisitions it is also necessary for the Corporate Development department to be strengthened. The search for a Head of Corporate Development is underway. About Tecan Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN: 1210019). For further information: Tecan Group Martin Braendle Head of Corporate Communications & Investor Relations Tel. +41 (0) 44 922 84 30 Fax +41 (0) 44 922 88 89 investor@tecan.com www.tecan.com Press Release (PDF): hugin.info/100384/R/1673974/545021.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Tecan Group AG via Thomson Reuters ONE [HUG#1673974]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com